Literature DB >> 2997262

Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man.

R Gerzer, H Witzgall, J Tremblay, J Gutkowska, P Hamet.   

Abstract

We studied the effects of a bolus injection of 50/micrograms synthetic human atrial natriuretic factor (ANF) on the cyclic GMP and cyclic AMP levels in plasma and urine of eight normal men. Administration of the hormone increased basal immunoreactive (IR-) ANF levels in plasma 2.8-fold to 110 pM three minutes after injection. Thereafter, IR-ANF levels rapidly declined to basal levels. Plasma cyclic GMP levels increased 2.6-fold to 16.6 nM within 6 minutes after ANF and decreased to near basal values within 30 minutes. Urinary cyclic GMP excretion increased 2.8-fold, whereas urinary volume and sodium excretion increased less than two-fold in the 30 minutes after ANF. Plasma cyclic AMP levels did not change. The data indicate that changes in plasma IR-ANF levels are followed by changes in plasma cyclic GMP and in urinary cyclic GMP excretion and suggest that cyclic GMP is a biological marker for circulating ANF in man.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997262     DOI: 10.1210/jcem-61-6-1217

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Atrial natriuretic peptide and water and electrolyte transport in the human jejunum.

Authors:  J Brunner; R Lübcke; G O Barbezat; T G Yandle; E A Espiner
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

2.  Effect of molsidomine on ex vivo platelet aggregation and plasma guanosine 3':5'-cyclic monophosphate levels in healthy volunteers.

Authors:  B Karrenbrock; J M Heim; R Gerzer
Journal:  Klin Wochenschr       Date:  1990-02-15

3.  Impact of acute and chronic sodium loading on atrial natriuretic peptide and renin in man.

Authors:  G Wambach; M Stimpel; G Bönner; S Degenhardt; W Kaufmann
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

Review 4.  Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction.

Authors:  Miguel Pinilla-Vera; Virginia S Hahn; David A Kass
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

5.  Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.

Authors:  T Fujita; Y Ito; H Noda; Y Sato; K Ando; K Kangawa; H Matsuo
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

6.  Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loading.

Authors:  J Weil; R E Lang; H Suttmann; U Rampf; F Bidlingmaier; R Gerzer
Journal:  Klin Wochenschr       Date:  1985-12-16

7.  Effect of prolonged physical exercise on fluid regulating hormones.

Authors:  H U Altenkirch; R Gerzer; K A Kirsch; J Weil; B Heyduck; I Schultes; L Röcker
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

8.  Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.

Authors:  G Jakob; J Mair; M Pichler; B Puschendorf
Journal:  Br Heart J       Date:  1995-02

9.  Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure.

Authors:  J M Costello; C L Backer; P A Checchia; C Mavroudis; R G Seipelt; D M Goodman
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

10.  Presence of atrial natriuretic factor and cyclic guanosine monophosphate in saliva. Comparison of plasma and salivary concentrations during a head-down tilt.

Authors:  G Gauquelin; A Maillet; A M Allevard; D Vorobiev; A I Grigoriev; C Gharib
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.